Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis
Sami Qadri,
Emilia Vartiainen,
Mari Lahelma,
Kimmo Porthan,
An Tang,
Ilkay S. Idilman,
Jurgen H. Runge,
Anne Juuti,
Anne K. Penttilä,
Juhani Dabek,
Tiina E. Lehtimäki,
Wenla Seppänen,
Johanna Arola,
Perttu Arkkila,
Jaap Stoker,
Musturay Karcaaltincaba,
Michael Pavlides,
Rohit Loomba,
Claude B. Sirlin,
Taru Tukiainen,
Hannele Yki-Järvinen
Affiliations
Sami Qadri
Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Corresponding authors. Address: Biomedicum Helsinki 1, Room A418a, Haartmaninkatu 8, 00290 Helsinki, Finland. Tel: +358-50-562-6899.
Emilia Vartiainen
Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland
Mari Lahelma
Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland
Kimmo Porthan
Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland
An Tang
Department of Radiology, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada
Ilkay S. Idilman
Liver Imaging Team, Hacettepe University, School of Medicine, Department of Radiology, Ankara, Turkey
Jurgen H. Runge
Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Anne Juuti
Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Anne K. Penttilä
Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Juhani Dabek
Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland
Tiina E. Lehtimäki
HUS Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland
Wenla Seppänen
HUS Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland
Johanna Arola
Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Perttu Arkkila
Department of Gastroenterology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
Jaap Stoker
Department of Radiology and Nuclear Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Musturay Karcaaltincaba
Liver Imaging Team, Hacettepe University, School of Medicine, Department of Radiology, Ankara, Turkey
Michael Pavlides
Radcliffe Department of Medicine, University of Oxford, Oxford, UK
Rohit Loomba
NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Diego, La Jolla, CA, USA
Claude B. Sirlin
Liver Imaging Group, Department of Radiology, University of California San Diego, La Jolla, CA, USA
Taru Tukiainen
Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland
Hannele Yki-Järvinen
Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Corresponding authors. Address: Biomedicum Helsinki 1, Room A418a, Haartmaninkatu 8, 00290 Helsinki, Finland. Tel: +358-50-562-6899.
Background & Aims: Pathologists quantify liver steatosis as the fraction of lipid droplet-containing hepatocytes out of all hepatocytes, whereas the magnetic resonance-determined proton density fat fraction (PDFF) reflects the tissue triacylglycerol concentration. We investigated the linearity, agreement, and correspondence thresholds between histological steatosis and PDFF across the full clinical spectrum of liver fat content associated with non-alcoholic fatty liver disease. Methods: Using individual patient-level measurements, we conducted a systematic review and meta-analysis of studies comparing histological steatosis with PDFF determined by magnetic resonance spectroscopy or imaging in adults with suspected non-alcoholic fatty liver disease. Linearity was assessed by meta-analysis of correlation coefficients and by linear mixed modelling of pooled data, agreement by Bland–Altman analysis, and thresholds by receiver operating characteristic analysis. To explain observed differences between the methods, we used RNA-seq to determine the fraction of hepatocytes in human liver biopsies. Results: Eligible studies numbered 9 (N = 597). The relationship between PDFF and histology was predominantly linear (r = 0.85 [95% CI, 0.80–0.89]), and their values approximately coincided at 5% steatosis. Above 5% and towards higher levels of steatosis, absolute values of the methods diverged markedly, with histology exceeding PDFF by up to 3.4-fold. On average, 100% histological steatosis corresponded to a PDFF of 33.0% (29.5–36.7%). Targeting at a specificity of 90%, optimal PDFF thresholds to predict histological steatosis grades were ≥5.75% for ≥S1, ≥15.50% for ≥S2, and ≥21.35% for S3. Hepatocytes comprised 58 ± 5% of liver cells, which may partly explain the lower values of PDFF vs. histology. Conclusions: Histological steatosis and PDFF have non-perfect linearity and fundamentally different scales of measurement. Liver fat values obtained using these methods may be rendered comparable by conversion equations or threshold values. Impact and implications: Magnetic resonance-proton density fat fraction (PDFF) is increasingly being used to measure liver fat in place of the invasive liver biopsy. Understanding the relationship between PDFF and histological steatosis fraction is important for preventing misjudgement of clinical status or treatment effects in patient care. Our analysis revealed that histological steatosis fraction is often significantly higher than PDFF, and their association varies across the spectrum of fatty liver severity. These findings are particularly important for physicians and clinical researchers, who may use these data to interpret PDFF measurements in the context of histologically evaluated liver fat content.